|
|
Volumn 1, Issue 3, 2008, Pages 317-320
|
|
Lessons From the Development of New Adenosine A2a Receptor Agonists**Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE;
ADENOSINE A2A RECEPTOR;
ADENOSINE A2A RECEPTOR AGONIST;
APODENOSON;
BINODENOSON;
PURINE NUCLEOSIDE;
REGADENOSON;
CLINICAL TRIAL;
CORONARY ARTERY BLOOD FLOW;
CORONARY ARTERY DILATATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG TOLERABILITY;
DYSPNEA;
EDITORIAL;
FLOW RATE;
FLUSHING;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE PERFUSION;
HUMAN;
IMAGE ANALYSIS;
IMAGING SYSTEM;
PRIORITY JOURNAL;
SCORING SYSTEM;
SIDE EFFECT;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
THORAX PAIN;
ADENOSINE;
CORONARY CIRCULATION;
HUMANS;
IMAGE INTERPRETATION, COMPUTER-ASSISTED;
MYOCARDIAL ISCHEMIA;
MYOCARDIAL PERFUSION IMAGING;
MYOCARDIUM;
PREDICTIVE VALUE OF TESTS;
PURINES;
PYRAZOLES;
RECEPTOR, ADENOSINE A2A;
REPRODUCIBILITY OF RESULTS;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
|
EID: 43549110510
PISSN: 1936878X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcmg.2008.03.003 Document Type: Editorial |
|
Times cited : (8)
|
|
References (17)
|
